CLINICAL_TRIALS ClinicalTrials.gov record update

Follow-up to Evaluate the the Immunogenicity & Safety of GSK Biologicals' MMRV Vaccine Given as a Two-dose Schedule in the Second Year of Life, as Compared to Separate Administration of GSK Biologicals' Priorix® & Varilrix®.

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00406211
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:26.384011+00:00
Published At: 2016-09-15T00:00:00+00:00
Record Updated At: 2016-09-15
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Rubella", "Varicella", "Mumps", "Measles"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2016-09-15"
protocolSection.identificationModule.nctId: "NCT00406211"
protocolSection.identificationModule.officialTitle: "Follow-up to Evaluate the the Immunogenicity \u0026 Safety of GSK Biologicals\u0027 MMRV Vaccine Given as a Two-dose Schedule in the Second Year of Life, as Compared to Separate Administration of GSK Biologicals\u0027 Priorix\u00ae \u0026 Varilrix\u00ae."
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.